Henry Schein, Inc. HSIC shares trading higher on Thursday, after the company announced the availability of its Standard Q coronavirus test.
The antibody rapid blood test, known as Standard Q COVID-19 IgM/IgG rapid test delivers results within 15 minutes from a pinprick with no instrumentation required.
Henry Schein is an American distributor of healthcare products and services with a presence in 32 countries.
Henry Schein shares were trading up 7% at $53.56 on Thursday. The stock has a 52-week range between $73.99 and $41.85.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.